RenovoRx, Inc. (RNXT)
1.14
-0.05
(-4.20%)
USD |
NASDAQ |
Oct 16, 16:00
1.15
+0.01
(+0.88%)
After-Hours: 20:00
RenovoRx Net Income (TTM) : -12.28M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.28M |
| March 31, 2026 | -12.27M |
| December 31, 2025 | -11.17M |
| September 30, 2025 | -11.10M |
| June 30, 2025 | -10.66M |
| March 31, 2025 | -10.16M |
| December 31, 2024 | -8.814M |
| September 30, 2024 | -9.163M |
| June 30, 2024 | -8.113M |
| March 31, 2024 | -8.051M |
| December 31, 2023 | -10.23M |
| Date | Value |
|---|---|
| September 30, 2023 | -9.161M |
| June 30, 2023 | -9.876M |
| March 31, 2023 | -10.14M |
| December 31, 2022 | -9.889M |
| September 30, 2022 | -10.09M |
| June 30, 2022 | -9.463M |
| March 31, 2022 | -8.179M |
| December 31, 2021 | -6.324M |
| September 30, 2021 | -5.065M |
| June 30, 2021 | -4.327M |
| March 31, 2021 | -4.068M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Enanta Pharmaceuticals, Inc. | -63.23M |
| Travere Therapeutics, Inc. | -67.68M |
| REGENXBIO, Inc. | -196.43M |
| Krystal Biotech, Inc. | 241.46M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |